Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 18 | 2022 | 229 | 6.040 |
Why?
|
| Tachycardia, Ventricular | 11 | 2023 | 153 | 5.110 |
Why?
|
| Arrhythmias, Cardiac | 9 | 2023 | 239 | 2.720 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2017 | 61 | 1.180 |
Why?
|
| Echocardiography | 2 | 2020 | 515 | 1.130 |
Why?
|
| Atrial Fibrillation | 5 | 2021 | 249 | 0.990 |
Why?
|
| Syncope, Vasovagal | 2 | 2021 | 5 | 0.970 |
Why?
|
| Endocardium | 3 | 2022 | 101 | 0.760 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2021 | 119 | 0.690 |
Why?
|
| Defibrillators, Implantable | 2 | 2020 | 329 | 0.630 |
Why?
|
| Holidays | 1 | 2018 | 3 | 0.630 |
Why?
|
| Therapeutic Irrigation | 3 | 2022 | 63 | 0.620 |
Why?
|
| Cardiac Electrophysiology | 1 | 2017 | 2 | 0.610 |
Why?
|
| Cardiologists | 1 | 2017 | 9 | 0.610 |
Why?
|
| Inservice Training | 1 | 2017 | 68 | 0.590 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 136 | 0.550 |
Why?
|
| Cardiology | 1 | 2017 | 140 | 0.540 |
Why?
|
| Heart Ventricles | 6 | 2022 | 738 | 0.540 |
Why?
|
| Stroke | 2 | 2021 | 2163 | 0.540 |
Why?
|
| Cardiac Catheters | 1 | 2015 | 12 | 0.530 |
Why?
|
| Educational Measurement | 1 | 2017 | 254 | 0.530 |
Why?
|
| Clinical Competence | 2 | 2017 | 657 | 0.520 |
Why?
|
| Health Expenditures | 1 | 2017 | 170 | 0.510 |
Why?
|
| Cardiac Catheterization | 2 | 2021 | 419 | 0.470 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 468 | 0.440 |
Why?
|
| Hospitalization | 1 | 2017 | 978 | 0.390 |
Why?
|
| Ventricular Premature Complexes | 2 | 2022 | 10 | 0.390 |
Why?
|
| Treatment Outcome | 9 | 2022 | 7029 | 0.390 |
Why?
|
| Humans | 25 | 2023 | 68618 | 0.390 |
Why?
|
| Pulmonary Veins | 2 | 2020 | 56 | 0.340 |
Why?
|
| Vagus Nerve | 3 | 2021 | 90 | 0.280 |
Why?
|
| Cardiomyopathies | 2 | 2022 | 167 | 0.270 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2023 | 98 | 0.250 |
Why?
|
| Electrocardiography | 4 | 2022 | 601 | 0.210 |
Why?
|
| Epicardial Mapping | 1 | 2022 | 4 | 0.210 |
Why?
|
| Equipment Design | 3 | 2022 | 500 | 0.210 |
Why?
|
| Heart | 3 | 2022 | 850 | 0.200 |
Why?
|
| Deep Sedation | 1 | 2021 | 11 | 0.200 |
Why?
|
| Pericardium | 1 | 2022 | 97 | 0.200 |
Why?
|
| Young Adult | 4 | 2021 | 5717 | 0.190 |
Why?
|
| Aged | 5 | 2021 | 14862 | 0.190 |
Why?
|
| Female | 8 | 2021 | 38074 | 0.180 |
Why?
|
| Atrial Flutter | 1 | 2019 | 16 | 0.170 |
Why?
|
| Tricuspid Valve | 1 | 2019 | 42 | 0.170 |
Why?
|
| Models, Animal | 3 | 2015 | 252 | 0.160 |
Why?
|
| Action Potentials | 1 | 2019 | 223 | 0.160 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 221 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2021 | 705 | 0.150 |
Why?
|
| Retrospective Studies | 2 | 2022 | 7277 | 0.150 |
Why?
|
| Heart Rate | 1 | 2019 | 568 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2019 | 267 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2019 | 622 | 0.140 |
Why?
|
| Male | 7 | 2021 | 37321 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1465 | 0.130 |
Why?
|
| Swine | 3 | 2022 | 672 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2016 | 116 | 0.130 |
Why?
|
| United States | 2 | 2017 | 7367 | 0.130 |
Why?
|
| Middle Aged | 5 | 2021 | 21147 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2017 | 403 | 0.130 |
Why?
|
| Hot Temperature | 1 | 2015 | 152 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2015 | 131 | 0.120 |
Why?
|
| Dogs | 1 | 2015 | 490 | 0.120 |
Why?
|
| Materials Testing | 1 | 2015 | 263 | 0.120 |
Why?
|
| Muscular Dystrophies | 1 | 2014 | 17 | 0.120 |
Why?
|
| Adult | 4 | 2021 | 21403 | 0.120 |
Why?
|
| Animals | 8 | 2022 | 20881 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2019 | 2007 | 0.110 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2013 | 35 | 0.110 |
Why?
|
| Heart Failure | 1 | 2021 | 1180 | 0.100 |
Why?
|
| gamma Catenin | 1 | 2011 | 11 | 0.100 |
Why?
|
| Desmosomes | 1 | 2011 | 14 | 0.100 |
Why?
|
| Ethanol | 1 | 2018 | 893 | 0.100 |
Why?
|
| Time Factors | 1 | 2019 | 4655 | 0.100 |
Why?
|
| Risk Factors | 2 | 2019 | 5731 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2019 | 1615 | 0.100 |
Why?
|
| Myocarditis | 1 | 2011 | 49 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 786 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 4848 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 117 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 2009 | 17 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2022 | 3705 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2009 | 200 | 0.080 |
Why?
|
| Adolescent | 2 | 2019 | 8912 | 0.080 |
Why?
|
| Heart Conduction System | 1 | 2009 | 119 | 0.080 |
Why?
|
| Recurrence | 2 | 2022 | 948 | 0.080 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 95 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 79 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 498 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 202 | 0.070 |
Why?
|
| Observational Studies as Topic | 1 | 2022 | 39 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 694 | 0.050 |
Why?
|
| Sheep | 1 | 2022 | 128 | 0.050 |
Why?
|
| Bradycardia | 1 | 2021 | 45 | 0.050 |
Why?
|
| Cicatrix | 1 | 2022 | 60 | 0.050 |
Why?
|
| Thermography | 1 | 2021 | 20 | 0.050 |
Why?
|
| Gadolinium | 1 | 2022 | 88 | 0.050 |
Why?
|
| Conscious Sedation | 1 | 2021 | 61 | 0.050 |
Why?
|
| Lasers | 1 | 2020 | 61 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2021 | 174 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 341 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 586 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2020 | 152 | 0.040 |
Why?
|
| Contrast Media | 1 | 2022 | 595 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 1342 | 0.040 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 442 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 2358 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 931 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3259 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 122 | 0.030 |
Why?
|
| Syndrome | 1 | 2014 | 255 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2011 | 32 | 0.020 |
Why?
|
| Autopsy | 1 | 2011 | 56 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 71 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2011 | 62 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 101 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 2011 | 77 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 371 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2011 | 330 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 14 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 540 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 626 | 0.020 |
Why?
|
| Zebrafish | 1 | 2009 | 187 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 141 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1553 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 947 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2008 | 249 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2008 | 241 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2673 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 848 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 5300 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 2689 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 940 | 0.010 |
Why?
|
| Child | 1 | 2011 | 6405 | 0.010 |
Why?
|